Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 20, 2020 - Issue 2
Submit an article Journal homepage
2,512
Views
1
CrossRef citations to date
0
Altmetric
Original Research

A modeling framework for the economic evaluation of baricitinib in moderate-to-severe rheumatoid arthritis

Max SchlueterReal World Solutions, IQVIA, London, UKCorrespondence[email protected]
View further author information
,
Peter RouseReal World Solutions, IQVIA, London, UKORCID Iconhttps://orcid.org/0000-0001-8480-6607View further author information
ORCID Icon,
Ashley PitcherReal World Solutions, IQVIA, London, UKView further author information
,
Peita Louise Graham-ClarkeGlobal Patient Reported Outcomes and Real World Evidence (GPORWE) International, Eli Lilly, West Ryde, AustraliaView further author information
,
Claudia NicolayInternational Statistics, Lilly Deutschland GmbH, Bad Homburg, GermanyView further author information
&
Walid FakhouriGlobal Patient Reported Outcomes and Real World Evidence (GPORWE) International, Eli Lilly, Windlesham, UKView further author information
Pages 221-228 | Received 03 Sep 2019, Accepted 16 Mar 2020, Published online: 25 Mar 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.